GlassScriptPhysician profile
Richard J Macchia
NPI 1720082282
$993.84
in general payments reported to CMS, 2019-2025
20 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.15 · 2020: $90.20 · 2021: $19.57 · 2022: $327 · 2023: $149 · 2024: $252 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $140.46 | 2024 | Bard Urinary Drainage Bag |
| Medtronic, INC. | $114.31 | 2022 | |
| Boston Scientific Corporation | $98.40 | 2020-2024 | |
| Urogen Pharma, INC. | $79.31 | 2023-2025 | Jelmyto |
| Myriad Genetic Laboratories, INC. | $63.26 | 2022-2023 | Myrisk |
| Tolmar Pharmaceuticals, INC. | $60.21 | 2021-2022 | |
| Procept Biorobotics Corporation | $51.41 | 2024-2025 | Aquabeam System |
| Merck Sharp & Dohme LLC | $49.82 | 2022-2025 | Keytruda, Welireg |
| Janssen Biotech, INC. | $46.42 | 2023-2024 | Erleada |
| Koelis INC. | $45.17 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.88 | 2022-2023 | |
| Convatec INC. | $40.08 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $28.04 | 2025 | Orgovyx |
| Astellas Pharma US INC | $24.59 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $24.26 | 2025 | Bard Urinary Drainage Bag |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $18.48 | 2023 | |
| Coloplast Corp | $17.92 | 2023 | Self-Cath |
| Abbvie INC. | $17.30 | 2025 | |
| Olympus America INC. | $16.71 | 2020 | |
| Foundation Medicine, INC. | $12.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Macchia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.